-Evidence implicates ferroptosis, an emerging iron-mediated cell death, as a pathway to effectively eradicate uveal melanoma in proof-of-concept animal models -HSB-1216, a novel ferroptosis inducer ...

Here is a breakdown of some of the important information surrounding uveal melanoma, an extremely rare form of cancer. Uveal melanoma is a rare form of eye cancer that many patients may not be aware ...

NEW YORK, November, 17, 2010 — An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer.

Clinical trials seek to discover new ways to attack the disease, limit metastasis and prevent recurrence. JESSE WALDINGER'S tumor was found during an eye exam. Fortunately, it was discovered early and ...

A geneticist has discovered a gene mutation that can cause the most common eye cancer -- uveal melanoma. The genetic mutation in a gene called GNAQ could be responsible for 45 percent of the cases of ...

Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) is a rare paraneoplastic syndrome in which diffuse proliferation of melanocytes within the uveal tract leads to significant ocular morbidity.

SURESNES, France and SOUTH SAN FRANCISCO, Calif., Sept. 2, 2025 SURESNES, France and SOUTH SAN FRANCISCO, Calif., Sept. 2, 2025 /PRNewswire/ -- Servier, an ...

New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells ...

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 11 December 2024) The European Organisation for Research and Treatment of Cancer (EORTC), an independent clinical cancer research ...

Racial, ethnic, and socioeconomic status disparities exist in uveal melanoma treatment and survival, according to a study published in JAMA Ophthalmology. “Histopathologic studies have reported that ...

Servier, an independent international pharmaceutical group governed by a foundation, and IDEAYA Biosciences, Inc., a leading precision medicine oncology company, announced an exclusive license ...